Clinical Trial Update: Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study evaluating the efficacy and safety of PBI-05204 in patients with stage IV metastatic pancreatic adenocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• PBI-05204

Snippet

Sponsor: Phoenix Biotechnology, Inc | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN